🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Moleculin’s $9.3m raise adds 49.5m potential shares after MIRACLE update

Cytokinetics secures UK approval and NHS access for aficamten in obstructive HCM

Novo Nordisk’s $2.1bn Corvidia bet faces impairment after ZEUS trial miss

Pakistan suicide bombing kills at least 14 at anti-militant peace rally in Swat

Global developments shaping business, policy, and markets